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Immunoglubolin dynamics and 
cancer prevalence in Tasmanian 
devils (Sarcophilus harrisii)
Beata Ujvari1,2, Rodrigo Hamede3, Sarah Peck2,4, David Pemberton4, Menna Jones3, 
Katherine Belov2 & Thomas Madsen1,5,6
Immunoglobulins such as IgG and IgM have been shown to induce anti-tumour cytotoxic activity. In 
the present study we therefore explore total serum IgG and IgM expression dynamics in 23 known-
aged Tasmanian devils (Sarcophilus harrisii) of which 9 where affected by Devil Facial Tumour Disease 
(DFTD). DFTD is clonally transmissible cancer that has caused massive declines in devil numbers. Our 
analyses revealed that IgM and IgG expression levels as well as IgM/IgG ratios decreased with increasing 
devil age. Neither age, sex, IgM nor IgG expression levels affected devil DFTD status in our analyses. 
However, devils with increased IgM relative to IgG expression levels had significantly lower DFTD 
prevalence. Our results therefore suggest that IgM/IgG ratios may play an important role in determining 
devil susceptibility to DFTD. We consequently propose that our findings warrant further studies to 
elucidate the underpinning(s) of devil IgM/IgG ratios and DFTD status.
Since its first sighting in 1996, the Tasmanian Devil Facial Tumour Disease (DFTD) has caused massive (> 85%) 
population declines of Tasmanian devils (Sarcophilus harrisii), hence questioning the long-term survival of this 
iconic species1. This highly contagious and clonally transmissible cancer is spread among individual devils via 
biting during social interactions2. DFTD cells are able to avoid host immune recognition by down-regulating 
MHC expression3. Metabolic failure, tumour related cachexia and metastases result in devil death within 6 to 9 
months of the emergence of the first lesions2.
Presently, no therapy to reduce the devastating effects of DFTD has been developed. Numerous studies have, 
however, demonstrated that IgM antibodies provide extended tumour immunosurveillance as well as anti-tumour 
cytotoxic activity in other organisms4–9, and IgM antibody therapy has been shown to reduce neuroblastoma and 
melanoma in humans10,11. In the present study we therefore investigate the effects of total serum IgG and IgM 
antibody expression dynamics on DFTD prevalence in the world’s largest surviving marsupial carnivore; the 
Tasmanian devil.
Results
Total serum IgM and IgG expression levels decreased with increasing devil age, and a single factor heterogeneity 
of slopes test with antibody as factor, age as covariate and antibody expression as dependent variable revealed a 
steeper age-specific decline in IgM compared to IgG expression levels (F3,42 = 24.24, p < 0.0001; age: F1 = 57.46, 
p < 0.0001; antibody: F1 = 6.29, p = 0.016; slope: age*antibody: F1 = 9.0, p = 0.0046, Fig. 1). Moreover, using a 
simple linear regression our analyses also revealed that IgM/IgG expression ratios decreased with increasing devil 
age (r2 = 0.70, p < 0.0001, N = 23; Fig. 2).
Using logistic regression we subsequently investigated whether the independent effects of devil age, sex, IgG 
and IgM expression as well as IgM/IgG ratio, and any of the possible two-way interactions between the five fac-
tors affected devil DFTD status. Following Quinn and Keough12 backward elimination was set at P > 0.2 which 
revealed that only devil IgM/IgG expression ratio had a significant effect on Devil DFTD status (Wald test, final 
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model IgM/IgG ratio: χ 2 = 5.90, p = 0.015, df = 1). Thus, devils with increased IgM relative to IgG expression 
levels had significantly lower DFTD prevalence (Fig. 3).
Discussion
IgM antibody titers have been shown to increase with advancing age in numerous vertebrates and IgM dynamics 
has therefore been suggested to play a crucial role in maintaining immunocompetence during the ageing pro-
cess13. The decline of IgM expression levels with increasing age suggests that devils are subjected to a significant 
age-related decline in immune function.
Although an experimental study showed that some devils are able to mount a specific IgG immune response to 
DFTD14 we did not observe any significant effects of IgG expression levels on DFTD status. As mentioned above, 
IgM antibodies have been shown to induce anti-tumour cytotoxic activity but in spite of this we did not detect any 
association between devil IgM expression levels and devil DFTD status.
DFTD prevalence has been shown to increase with increasing devil age1. However, the results from the pres-
ent study demonstrate that only IgM/IgG expression levels, and not age, had a significant impact on devil DFTD 
Figure 1. Relationship between IgM and IgG expression level and devil age. 
Figure 2. Relationship between IgM/IgG expression ratio and devil age. 
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status. In humans IgM/IgG antibody ratio has been shown to play a crucial role in resistance to diseases such as 
cerebral small vessel disease15. Moreover, in mice challenged by melanoma cells, increased IgM relative to IgG 
titers resulted in regressed tumour growth whereas decreased IgM relative to IgG titers caused aggressive tumour 
progression4. Although we can not rule out that DFTD results in a reduction in IgM relative to IgG titers, the 
results from the present study mirror those obtained in mice i.e. increased IgM relative to IgG expression levels 
significantly reduced devil DFTD prevalence, highlighting the importance of IgM/IgG ratios in cancer aetiology. 
We consequently propose that our findings warrant further studies to elucidate the mechanisms of total IgM/IgG 
ratios and devil DFTD prevalence.
Although active immunotherapy has not yet become the “magic bullet” in cancer treatment16, the results 
from the present study suggest the importance of IgM/IgG ratios in devil carcinogenesis. The development of 
anti-tumour vaccines that enhance the production of IgM relative to IgG antibodies and/or direct treatment with 
IgM antibodies such as PAT-SM611 may therefore become an important component in combating the devastating 
effects of DFTD on devil population demography.
Materials and Methods
Animals, age and DFTD scoring. Twenty three devils (10 females and 13 males) were blood sampled 
(500 μ l/sample) in March and May 2012 at “West Pencil Pine”, 15 km to the west of Cradle Mountain National 
Park in north-west Tasmania. Devil age was determined by using 20th of March as the mean birth date and repre-
sented 8 age groups ranging from 12 to 48 months (for further details on aging see Hamede et al.17). Disease status 
was assessed by visual inspection of tumours and/or by histopathological examination of biopsies collected from 
tumours17. Of the 23 devils, 14 showed no clinical signs of being infected whereas 9 were confirmed to be infected 
by DFTD. The methods were carried in accordance with the approved guidelines of the University of Tasmania’s 
Animal Ethics Committee (A0010296), and all experimental protocols were approved by the University of 
Tasmania’s Animal Ethics Committee (A0010296).
RNA extraction and quantifying IgM and IgG expression by quantitative RT-PCR 
(qRT-PCR). RNA was extracted from blood samples using the RNeasy Protect Animal Blood Kit (Qiagen, 
Germantown, MD). Genomic DNA was removed from the RNA samples by the DNAse I AMPD1 kit (Sigma, St. 
Louis, MO) and cDNA was synthesized with the QuantiTect Reverse Transcription Kit (Qiagen, Germantown, 
MD).
Immunoglobulin heavy chain constant region segments were identified and sequenced as part of a previous 
study18 from the whole genome sequence of the Tasmanian devil available in the Ensembl database (DEVIL7.0, 
GCA_000189315.1)19. Only one transcript variant of IgM and IgG heavy chain constant regions have been iden-
tified the Ensembl database (DEVIL7.0, GCA_000189315.1)19. Gene specific primers were designed across exons 
of IgG (exon3 – exon4) and IgM (exon1 – exon2) heavy chain constant regions to avoid amplification of genomic 
DNA. The amplified cDNA products were cloned (using Topo-Ta Cloning (ThermoFisher Scientific, MA, USA) 
and sequenced using Sanger Sequencing to verify that functional IgM, IgG and RPS29 transcripts were amplified. 
The sequences have been deposited to GenBank under accession numbers: Saha-IgG: KU664590, Saha-RPS29: 
KU664591 and Saha-IgM: KU664592. Additionally melt curve analyses were conducted to confirm the lack of 
genomic DNA and primer dimers in the reaction (Supplementary Material).
cDNA was amplified without using primers from variable region sequences, thus allowing for a representative 
sampling of immunoglobulin genes expressed by circulating B cells. Our results therefore provide a “snapshot” of 
the levels of circulating IgG and IgM antibodies at the time of sampling.
Specific IgG and IgM primers were designed using the Primer3Plus website (http://www.bioinformatics.
nl/cgi-bin/primer3plus/primer3plus.cgi); IgG primers: qIgG-F: 5′-CAG GTG ATC AGC ACT CTC TCT G-3′ , 
Figure 3. Logistic relationship between Tasmanian devil DFTD status (1 = infected; 0 = uninfected) and 
I gM/IgG expression ratio. 
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qIgG-R: 5′-GGA TGT GGG GC AAG ACA TA-3′ , IgM primers: qIgHM-F: 5′ -TTT GAT ATC TGG GGC AAA 
GG-3′ , qIgHM-R: 5′ -ACA GCA AAG GAG GCA TCT TC-3′ . To control for the potential of cell-type specific 
gene expression of reference genes three housekeeping genes were tested, glyceraldehyde 3-phosphate dehydro-
genase (GAPDH), ornithine decarboxylase antizyme (OAZ) and 40S ribosomal protein S29 (RPS29) by using the 
software package BestKeeper20 which generates a Bestkeeper index by calculating and combining the geometric 
mean of the cycle threshold values (Ct values) for each sample across all housekeeping genes. Pearson correlation 
coefficients were subsequently used to compare each individual gene in a pair-wise fashion to the BestKeeper 
index, followed by ranking the candidate genes in order of their stability. The highest ranked gene is the most 
stable, and most suitable to be used as normalizer gene. To determine the most stable housekeeping gene, 7 ran-
domly chosen samples were run with each housekeeping genes, GAPDH, OAZ and RPS29, and the obtained Ct 
values were analyzed by using the Bestkeeper software. RPS29 had the highest correlation coefficient (r): 0.981 
(GAPDH r: 0.951, OAZ r: 0.694), therefore we ranked that gene the highest and used it as the reference gene in 
the subsequent analyses.
Similar to the IgG and IgM primers, gene specific primers were designed across exons of RPS29 (exon1 – 
exon2, only one transcript identified): RPS29-F: 5′ -ATG GGT CAT CAG CAG CTC TAC-3′ , RPS29-R: 5′ -AGG 
CCG TAT TTG CGG ATT AG-3′ ). Quantitative RT-PCR was conducted on the RotorGene6000 (Qiagen, 
Germantown, MD). Standard curves (r2 > 0.99) contained five dilutions from the dilution series with a linear 
dynamic range of at least 3 orders of magnitude. PCR efficiencies ranged between 0.94 and 1.07 (IgG: 0.94, IgM: 
1.04 and RPS29: 1.00). All samples were run in quadruplicate, and all Cq values for unknowns fell within the lin-
ear quantifiable range of the appropriate standard curves. Controls containing no reverse transcriptase enzymes, 
and controls containing no cDNA samples were run alongside the reactions to confirm that no genomic DNA was 
amplified, and the lack of primer dimers in the reactions, respectively (Supplementary Material). The program 
REST21 was used to calculate the normalized fold change of target compared with the reference gene.
Statistical analyses. IgG and IgM expressions levels were ln-transformed to normalize distributions and to 
equalize variance across age groups. Analyses were carried out using JMP version 5.1.
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